Rennie tab. chewing. No. 24 with mint flavor
Package quantity, pcs:
12
24
48
Category
Heartburn
Scope of the medicinal product
Gastrointestinal tract
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
24
Dosage form
Sugar-free mint chewable tablets, white with a creamy shade, square, with concave surfaces, engraved with Rennie" on both sides, with a mint scent.
Structure
calcium carbonate 680 mg
magnesium hydroxycarbonate 80 mg
Excipients: sorbitol, pregelatinized corn starch, potato starch, talc, magnesium stearate, light liquid paraffin, mint flavor, sodium saccharinate.
pharmachologic effect
Heartburn drug.
It helps quickly (3-5 minutes), protects the mucous membrane of the stomach and esophagus, contains substances natural for the body (calcium and magnesium).
Local antacid preparation.
Contains calcium carbonate and magnesium carbonate, which provide fast and long-term neutralization of excess gastric acid hydrochloric acid, thereby providing a protective effect on the gastric mucosa.
The achievement of a therapeutic effect within 3-5 minutes is due to the good solubility of the tablets and the high calcium content.
Pharmacokinetics
Suction
As a result of the interaction of Rennie® with gastric juice, soluble calcium and magnesium salts are formed in the stomach.
The level of absorption of calcium and magnesium from these compounds depends on the dose of the drug.
The maximum absorption rate is 10% calcium and 15-20% magnesium.
Withdrawal
Small amounts of absorbed calcium and magnesium are excreted by the kidneys.
In the intestine, insoluble compounds are formed from soluble salts, which are excreted in the feces.
Pharmacokinetics in special clinical situations
With impaired renal function, the concentration of calcium and magnesium in plasma may increase.
Side effects
Allergic reactions: in very rare cases, a rash, Quincke's edema, anaphylactic reactions are possible.
If the recommended doses are observed, the drug is well tolerated.
Selling features
Available without a prescription
Special conditions
Patients with impaired renal function are not recommended to take the drug for a long time in high doses.
When prescribing the drug to patients with impaired renal function, the concentration of magnesium and calcium in the blood serum should be regularly monitored.
The use of Rennie® in high doses may increase the risk of kidney stones.
If it is necessary to prescribe the drug to patients with diabetes mellitus, it should be borne in mind that 1 Rennie® tablet with the menthol smell and 1 Rennie® tablet with the orange smell contain 475 mg of sucrose.
1 tablet Rennie® with mint scent contains 400 mg of sorbitol and saccharin and can be prescribed for patients with diabetes mellitus.
In case of ineffectiveness of treatment, the patient should consult a doctor.
Influence on the ability to drive vehicles and use mechanisms
The drug does not affect the ability to drive vehicles and other activities that require high concentration of attention and speed of psychomotor reactions.
Indications
Symptoms associated with increased acidity of gastric juice and reflux esophagitis (including those caused by errors in diet, medication, alcohol, coffee, nicotine abuse):
- heartburn
- belching
- recurrent pain in the stomach
- a feeling of fullness or heaviness in the epigastric region
- flatulence
- dyspepsia.
Dyspepsia of pregnant women
Contraindications
- severe renal failure
- hypercalcemia
- hypersensitivity to drug components.
Drug interactions
Medicines should be taken 1-2 hours before or after taking antacids.
With the simultaneous use of Rennie® reduces the absorption of tetracycline antibiotics, fluoroquinolones, phosphates.
Anticholinergic drugs enhance and prolong the effect of Rennie®, slowing down gastric emptying.
With the simultaneous use of Rennie® enhances the effect of sulfadiazine, levodopa, acetylsalicylic
Name ENG
RENNIE
Clinical and pharmacological group
Antacid drug
ATX code
Antacids, other combinations
Dosage
680mg + 80mg
Structure
calcium carbonate 680 mg.
magnesium hydroxycarbonate 80 mg.
Excipients: sorbitol, pregelatinized corn starch, potato starch, talc, magnesium stearate, light liquid paraffin, mint flavor, sodium saccharinate.
Indications
Symptoms associated with increased acidity of gastric juice and reflux esophagitis (including those caused by an error in diet, medication, alcohol, coffee, nicotine abuse):
heartburn
sour belching
recurrent pain in the stomach
feeling of fullness or heaviness in the epigastric region
dyspepsia
dyspepsia of pregnant women.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Contraindications
hypersensitivity to drug components
severe renal failure
hypercalcemia
hypophosphatemia
nephrocalcinosis
children under 12 years of age.
INN / Active ingredient
Magnesium carbonate + calcium carbonate
Specifications
Category
Heartburn
Scope of the medicinal product
Gastrointestinal tract
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
24
Scope of application
Gastroenterology
Minimum age from
12 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Rennie
The amount of the dosage form in the primary package
12 pcs.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antacid
Anatomical and therapeutic characteristics
A02AX Antacids, in combination with other drugs
Dosage form
Sugar Free Chewable Tablets [Mint]
The target audience
Children
Expiration date in days
1095
Package weight, g
40
Mode of application
:
For adults and children over the age of 12, if symptoms appear, 1-2 tablets should be chewed (or kept in the mouth until completely absorbed).
If necessary, you can repeat taking the drug after 2 hours. The maximum daily dose is 16 tablets.
Dosage (volume) of the substance in the preparation
:
1 tab .: calcium carbonate 680 mg, magnesium carbonate basic 80 mg
Information on technical characteristics, delivery set, country of manufacture "